| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 1.932 | 895 | 1.353 | 942 | 702 | 483 | -24 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | -1.932 | -895 | -1.353 | -942 | -702 | -483 | 24 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | -1.932 | -1.862 | -1.353 | -942 | -702 | -483 | 24 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Toximed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 35.339 | 34.741 | 34.103 | 33.443 | 32.809 | 32.081 | 32.181 | 32.083 | 31.904 |
| Current Assets | 15.776 | 15.749 | 14.733 | 14.455 | 14.180 | 13.912 | 13.561 | 13.627 | 13.585 | 13.509 |
| Inventories | 11.969 | 11.846 | 11.646 | 11.432 | 11.211 | 10.998 | 10.754 | 10.788 | 10.755 | 10.695 |
| Receivables | 3.165 | 3.136 | 3.080 | 3.023 | 2.965 | 2.908 | 2.830 | 2.839 | 2.830 | 2.814 |
| Cash | 643 | 767 | 8 | 0 | 4 | 6 | -23 | 0 | 0 | 0 |
| Shareholders Funds | -1.456 | -3.373 | -5.178 | -6.439 | -7.256 | -7.821 | -8.130 | -8.132 | -8.107 | -8.062 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.232 | 54.461 | 54.652 | 54.998 | 54.879 | 54.542 | 53.772 | 53.939 | 53.776 | 53.475 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7732 - 7732" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Toximed Srl